Zobrazeno 1 - 10
of 355
pro vyhledávání: '"Motohide, Uemura"'
Autor:
Yuki Yoshida, Soichiro Ogawa, Satoru Meguro, Akifumi Onagi, Ryo Tanji, Kanako Matsuoka, Seiji Hoshi, Junya Hata, Yuichi Sato, Hidenori Akaihata, Masao Kataoka, Motohide Uemura, Yoshiyuki Kojima
Publikováno v:
IJU Case Reports, Vol 7, Iss 3, Pp 197-200 (2024)
Introduction CHARGE syndrome is a rare disorder that causes congenital abnormalities in multiple organs, including secondary hypogonadism. We report, herein, a unique case of CHARGE syndrome with both primary and secondary hypogonadism and discuss th
Externí odkaz:
https://doaj.org/article/910dbdd6701f4a339c3ec13db7bb7702
Autor:
Masao Kataoka, Satoru Meguro, Ryo Tanji, Akifumi Onagi, Kanako Matsuoka, Ruriko Honda-Takinami, Seiji Hoshi, Junya Hata, Yuichi Sato, Hidenori Akaihata, Soichiro Ogawa, Motohide Uemura, Yoshiyuki Kojima
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract The present study investigated the role of a urethral support system to maintain urinary continence after robot-assisted radical prostatectomy (RARP), with a focus on pelvic floor muscles, such as the puboperinealis muscle (PPM) and rectoure
Externí odkaz:
https://doaj.org/article/1b8ffb28c2924577afc43aaa3be0b8c6
Autor:
Seiji Hoshi, Kei Yaginuma, Satoru Meguro, Akifumi Onagi, Kanako Matsuoka, Junya Hata, Yuichi Sato, Hidenori Akaihata, Masao Kataoka, Soichiro Ogawa, Motohide Uemura, Yoshiyuki Kojima
Publikováno v:
Current Oncology, Vol 30, Iss 8, Pp 7286-7302 (2023)
Theranostics (therapy + diagnosis) targeting prostate-specific membrane antigen (PSMA) is an emerging therapeutic modality that could alter treatment strategies for prostate cancer. Although PSMA-targeted radioligand therapy (PSMA-RLT) has a highly t
Externí odkaz:
https://doaj.org/article/fd81d48bad7d46b7a59d9cd5cc7fdede
Autor:
Shunta Makabe, Tomoyuki Koguchi, Kanako Matsuoka, Seiji Hoshi, Junya Hata, Yuichi Sato, Hidenori Akaihata, Masao Kataoka, Motohide Uemura, Yoshiyuki Kojima
Publikováno v:
IJU Case Reports, Vol 6, Iss 4, Pp 248-252 (2023)
Introduction Basal cell carcinoma of the prostate is rare, with no established treatment for its recurrence or metastasis. We report a case involving basal cell carcinoma of the prostate controlled using radiotherapy. Case presentation A 57‐year‐
Externí odkaz:
https://doaj.org/article/4f24f786e3094875b2b820b3ab31f98e
Autor:
Yuki Nishimura, Kazuaki Yamanaka, Taigo Kato, Koji Hatano, Atsunari Kawashima, Shinichiro Fukuhara, Motohide Uemura, Ryoichi Imamura, Norio Nonomura
Publikováno v:
IJU Case Reports, Vol 6, Iss 2, Pp 101-105 (2023)
Introduction Since the approval of immune checkpoint inhibitors for renal cell carcinoma treatment, therapeutic efficacy has been enhanced. However, although autoimmune‐related side effects may occur, rheumatoid immune‐related adverse events seld
Externí odkaz:
https://doaj.org/article/0ae7ef7b5f9741c4bf98fdbba67f4398
Autor:
Masaru Tani, Akira Nagahara, Shingo Takada, Kazutoshi Fujita, Shinichiro Fukuhara, Motohide Uemura, Hiroshi Kiuchi, Ryoichi Imamura, Norio Nonomura
Publikováno v:
IJU Case Reports, Vol 6, Iss 2, Pp 93-96 (2023)
Introduction Complete resection is essential for the treatment of teratoma with malignant transformation, and if metastasis occurs, it will be difficult to cure. We report a case of primary mediastinal teratoma with differentiation into angiosarcoma
Externí odkaz:
https://doaj.org/article/b393713a91324e50ab0553367c41e5c3
Autor:
Takanori Nate, Koji Hatano, Taigo Kato, Atsunari Kawashima, Toyofumi Abe, Shinichiro Fukuhara, Motohide Uemura, Hiroshi Kiuchi, Ryoichi Imamura, Norio Nonomura
Publikováno v:
IJU Case Reports, Vol 6, Iss 2, Pp 150-153 (2023)
Introduction A primary retroperitoneal mucinous cystadenoma should be surgically resected because of the risk of malignant transformation. However, mucinous cystadenoma of the renal parenchyma is very rare, and preoperative imaging mimics complicated
Externí odkaz:
https://doaj.org/article/c9bd0090f3604f2684e2520acc8e4953
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
In the treatment of cancer, understanding the disease status, or accurate staging, is extremely important, and various imaging techniques are used. Computed tomography (CT), magnetic resonance imaging, and scintigrams are commonly used for solid tumo
Externí odkaz:
https://doaj.org/article/b717b9d8a125489badcea57a9d0783aa
Autor:
Eisuke Tomiyama, Kazutoshi Fujita, Kosuke Nakano, Ken Kuwahara, Takafumi Minami, Taigo Kato, Koji Hatano, Atsunari Kawashima, Motohide Uemura, Tetsuya Takao, Hiroaki Fushimi, Kotoe Katayama, Seiya Imoto, Kazuhiro Yoshimura, Ryoichi Imamura, Hirotsugu Uemura, Norio Nonomura
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 3911-3921 (2022)
Trophoblast cell surface antigen 2 (Trop-2, encoded by TACSTD2) is the target protein of sacituzumab govitecan, a novel antibody-drug conjugate for locally advanced or metastatic urothelial carcinoma. However, the expression status of Trop-2 in upper
Externí odkaz:
https://doaj.org/article/0a4fb7c503704d7199085de8222c3759
Autor:
Akinaru Yamamoto, Atsunari Kawashima, Toshihiro Uemura, Gaku Yamamichi, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Taigo Kato, Koji Hatano, Motohide Uemura, Norio Nonomura
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background The pathological grading system for non-muscle-invasive bladder cancer is based on the WHO 2004/2016 classification system (low-grade: LG/high-grade: HG) and the WHO 1973 classification system (Grade 1: G1/Grade 2: G2/Grade 3: G3)
Externí odkaz:
https://doaj.org/article/dcc6d18748f14606808144831d154b77